Genentech is a biotechnology company dedicated to pursuing groundbreaking science to discover and develop medicines for people with serious and life-threatening diseases. Specific to their focus on OPHTHALMOLOGY and advances in understanding of disease biology, the chance to make a significant difference in the lives of people with ocular disorders has never been greater.
Genentech is focused on diseases of the eye that cause significant vision loss such as wet age-related macular degeneration, geographic atrophy, diabetic macular edema and glaucoma. By leveraging previous research conducted in our immunology, vascular biology and neurobiology groups, and applying it to pathologic conditions of the eye, we hope to shed new light and further our progress in understanding and treating ophthalmic diseases.
Genentech supports JDRF through educational grants to help further JDRF’s mission.